Advertisement

---

KEMPHARM, INC.

KemPharm, Inc. Receives Patent from the USPTO for Novel Pain Drug Candidate, KP201

Rubrique: Health Business news

[2013-06-11] -

KemPharm's KP201 Featured at the International Conference on Opioids

Rubrique: Health Business news

[2013-06-04] - Poster Presentation to Highlight KP201's Unique Abuse-Deterrent Properties and Its Potential to Prevent or Reduce Opioid-Induced Constipation

1
Advertisement
Most read: scientific news

---

---

---

---

---

30jours


---

---

---

---

---

90days


---

---

---

---

---

180days

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers